Free shipping on all orders over $ 500

PF-9363

Cat. No. M40815

All AbMole products are for research use only, cannot be used for human consumption.

PF-9363 Structure
Synonym:

CTx-648

Size Price Availability Quantity
1mg USD 80  USD80 In stock
5mg USD 200  USD200 In stock
10mg USD 300  USD300 In stock
50mg USD 650  USD650 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

PF-9363 is a first-in-class, orally active, highly selective KAT6A/B inhibitor for studies related to ER-positive breast cancer.

Chemical Information
Molecular Weight 444.46
Formula C20H20N4O6S
CAS Number 2569009-58-9
Form Solid
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Shikhar Sharma et al. Cell Chem Biol. Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetyltransferases with efficacy against KAT6A-high ER+ breast cancer

Related Histone Acetyltransferase Products
CBP/p300-IN-5 

P300/CBP-IN-5 is a potent p300/CBP histone acetyltransferase inhibitor, has an IC50 of 18.8 nM.

JG-2016

JG-2016 is a potent inhibitor of histone acetyltransferase 1 (HAT1), with an IC50 of 14.8 μM in the HAT1 acetylation assays.

AU-18069

AU-18069 is a CBP/p300 HAT inhibitor that can be used in studies related to hematological and solid tumors.

KAT modulator-1

KAT modulator-1 is a KAT modulator.

KAT6-IN-1

KAT6-IN-1 is a potent KAT6 inhibitor.

  Catalog
Abmole Inhibitor Catalog




Keywords: PF-9363, CTx-648 supplier, Histone Acetyltransferase, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.